Group items tagged

The Royal Pharmaceutical Society (RPS) has appointed James Davies as Director of England. Davies will be joining RPS in January 2023 to drive professional leadership for the pharmacy profession in England, working with and for RPS members. He'll lead on national policy development, professional advocacy and member engagement across England, in partnership with the English Pharmacy Board. Davies said: "It's a privilege to take up this position within the RPS, the professional home of pharmacy. I have been a member of the RPS throughout my pharmacy career, and that has helped me to continually drive excellence in pharmacy practice. I'm excited about delivering the current RPS strategy to ensure that pharmacy is, and continues to be, at the forefront of healthcare. I'm eager to work as part of the team and with the Board, leading and developing opportunities for the profession that improve the lives of patients and the public.

A University College London team of researchers has developed an artificial intelligence (AI) programme that can identify minute brain anomalies that lead to epileptic seizures. The algorithm, used in the Multicentre Epilepsy Lesion Detection project (MELD) and which reports locations of abnormalities in cases of drug-resistant focal cortical dysplasia (FCD) - a major cause of epilepsy - was developed by a multinational team who used more than 1,000 patient MRI scans from 22 international epilepsy centres. Brain regions known as FCDs have evolved improperly and frequently lead to drug-resistant epilepsy. Surgery is usually used to treat it, however, finding the lesions on an MRI is a constant problem for doctors because MRI scans for FCDs can appear normal. The scientists employed about 300,000 places throughout the brain to quantify cortical properties from the MRI scans, such as how thick or folded the cortex/brain surface was.

The Medicines and Healthcare products Regulatory Agency (MHRA) has authorised a new drug today (1 November) to treat severe alopecia areata. Litfulo is the new hard capsule medicine with a recommended dosage of just 50 mg per day. It contains an active ingredient, ritlecitinib, an enzyme inhibitor treatment for patients over 12 years. Ritlecitinib works by reducing the activity of enzymes in the body called JAK3 and TEC kinases that cause hair follicle inflammation. This reduction in inflammation leads to hair regrowth in patients with alopecia areata. Alopecia areata is an autoimmune disease, where the body's own immune system attacks hair follicles leading to hair loss on the scalp and other parts of the body.

Bestway Healthcare has appointed Jeremy Meader as its new chief wholesale officer, following the retirement of Anup Sodha. Meader would join the company in mid-November but is expected to officially assume his responsibilities from January 2, 2024. He will lead Lexon, Bestway Medhub, Wardle's, Knights Fragrances, PI & Specials manufacturing and the wholesale supply chain. Sodha, who co-founded the business 25 years ago, will continue to lead the company's wholesale business unit until 31 December 2023. Commenting on his retirement, Sodhi said: "I am proud of what we achieved at Lexon, it has been a team effort and I am grateful to everyone who has helped as we built a strong wholesale business.

Dr Amanda Doyle has been appointed as NHS England as director of primary and community care. Prior to her new role, Amanda had joined NHS England and NHS Improvement as North West Regional Director on 2 August 2021 and previously she was the Chief Clinical Officer for West Lancashire Clinical Commissioning Group (CCG), Blackpool CCG and Fylde and Wyre CCG. Amanda was also the Integrated Care System Lead for Lancashire and South Cumbria, leading a large health and care transformation programme across the patch. She has been a GP for more than 20 years, practising in a large practice in a deprived area of Blackpool, which, in addition to primary medical services, provides a range of urgent care services for patients across the Fylde Coast. Amanda was the Co-Chair of NHS Clinical Commissioners from 2013 to 2018. She was Senior Responsible Officer for the primary care component of the Long Term Plan and was involved in the leadership of the health inequalities, prevention and personalisation elements.

Two new subvariants of Omicron - BA.4 and BA.5 - are spreading much faster than other corovanirus variants in Europe, which could lead to more hospitalisations and deaths as they become dominant, the EU's disease prevention agency said on Monday (June 13). Most EU countries have so far detected low rates of the two subgroups. But in countries where the proportion has risen - such as Portugal, where BA.5 accounted for 87 per cent of cases by May 30 - there have been surges in overall cases, according to the European Centre for Disease Prevention and Control (ECDC). The two sublineages were added to the World Health Organization's monitoring list in March and have also been designated as variants of concern by the ECDC. Variants BA.4 and BA.5 do not appear to carry a higher risk of severe disease than other forms of Omicron.But an increase in case numbers from higher transmission rates risks leading to an increase in hospitalisations and deaths, the agency said. "The growth advantage reported for BA.4 and BA.5 suggest that these variants will become dominant," ECDC said in a statement on its website.

DE Group, one of the UK's leading independent pharmaceutical wholesalers, has gone into administration. Pharmacy Business has learnt that the group was put into administration on Monday (May 9), putting hundreds of jobs at risk and stoking fears of a "sudden shock" to pharmaceutical supply chain. A community pharmacy contractor who has done business with the wholesaler for over 20 years told Pharmacy Business: "I fear for the worst. I don't think there will be enough supply of medicines to cope up with a surge at such a short notice." Bharat Shah, founder and CEO of Sigma Pharmaceuticals, another leading short-line wholesaler, said the news will send shock-waves and have "a massive impact on the market" because DE Group enjoyed a "substantial coverage and market share" in the independent pharmacy sector. "It won't be easy for anyone to take on the extra volume as it could jeopardise their own business," he said, adding that Sigma was actively looking into expanding its own operations in the foreseeable future.

The Health and Social Care Secretary has announced over £175 million funding to boost genomics research in the UK. Through this funding, the government aims to create the most advanced genomic healthcare system in the world. "Patients with cancer and children born with treatable rare genetic diseases are set to benefit from earlier diagnosis and faster access to treatment, following a £175 million boost to cutting-edge genomics research announced by the Health and Social Care Secretary today (Tuesday)," said DHSC. The funding will enable research which could deliver world-leading genomic healthcare to patients, which involves the study of people's DNA. "£105 million to be funded to kickstart a world-leading research study, led by Genomics England in partnership with the NHS, to explore the effectiveness of using whole genome sequencing to find and treat rare genetic diseases in newborn babies," said DHSC. "An initial £26 million to support an innovative cancer programme, led by Genomics England in partnership with the NHS, to evaluate cutting-edge genomic sequencing technology to improve the accuracy and speed of diagnosis for cancer patients and use artificial intelligence to analyse a person's DNA, alongside other information such as routine scans.

The National Pharmacy Association (NPA) has announced the retirement of its Chief Executive, Mark Lyonette. Mark will retire in 2024. The association has announced his retirement well in advance so that the Board can start work with a leading recruitment agency to search for the new Chief Executive. "The Board is keen to build on the strong foundations established and ensure there is a seamless transition and minimum disruption to the business once the new Chief Executive is in post," said the association. Mark said: "After five years at the NPA and 40 years working for and leading national membership organisations, I am looking forward to living a different life. "I am pleased that in the time that I have been with the NPA we have grown both the membership and customer base and created a profitable, stable membership organisation. "Alongside our NPA Insurance company, the association is well set to help members face the future. "Meanwhile there is much to do to ensure that 2023 is another good year in terms of the NPA delivering consistently for members. The process of changing Chief Executive won't deflect us from our vital work."

An old proverb that comes to mind in the pursuit of the twin objectives of serenity and health is this: the mind and the body are inexorably intertwined. This essential, often overlooked, connection is at the heart of our ability to manage stress and foster a sense of well-being. But how does one truly achieve relaxation, and how does it translate to a healthier way of living? From ancient practices to modern breakthroughs, the path to stress relief and overall health is illuminated by a multifaceted approach that combines mindfulness, diet, exercise, and even the judicious use of calming products. The nexus between stress relief and well-being is rich and layered. By exploring various strategies, we can uncover the tapestry of tranquility that ultimately leads to a richer, more vital life. Relaxation Leads to a Healthier Mind and Body Relaxation is not just a warm bath or an hour of Netflix; it is the conscious unclenching of the mind and the body's release of tension. It's a critical ingredient in the complex recipe for overall health and plays a significant role in the functioning of the immune system, the maintenance of a healthy heart, and the regulation of moods. To relax, people take wellness CBD gummies that offer a natural, convenient route to unwind without the psychedelic effects often associated with the substance. Relaxation techniques also encompass meditation, deep breathing, progressive muscle relaxation, and guided imagery. Each method has its loyal practitioners, but the central tenet remains the same - in relaxation lies a wellspring of health.

Trauma can turn our world upside down, leaving scars that are not always visible. Whether it's a car accident, the loss of a loved one, or a natural disaster, serious trauma can deeply affect our mental health. Coping with such events is crucial not only for our immediate well-being but also for our long-term recovery. In this post, we'll explore six psychological tips to help you deal with the aftermath of a traumatic event. By integrating these strategies into your life, you can begin to heal and find a path forward. Keep on reading to learn more! Understanding Trauma What Is Trauma? Trauma is an emotional response to a distressing event or series of events. These events can overwhelm an individual's ability to cope, leading to feelings of helplessness, disorientation, and intense fear. Trauma is not limited to physical injuries; it can deeply affect emotional and mental health. How Trauma Affects the Brain When we experience trauma, our brain goes into survival mode. The amygdala, responsible for detecting threats, becomes overactive. Meanwhile, the prefrontal cortex, which helps with rational thinking, can become underactive. This imbalance can lead to heightened anxiety, flashbacks, and difficulty concentrating.

Researchers from King's College London and the University of Helsinki have identified a link between periodontitis (gum disease) and cryptogenic ischemic stroke, which causes a blockage in the blood vessel supplying blood to a region of the brain. The findings, recently published in the Journal of Dental Research, emphasise severe gum disease as a risk factor for young-onset stroke, particularly in patients with no other identifiable risk factors. Dr. Susanna Paju, Periodontology Specialist from the University of Helsinki, led the study in collaboration with Dr. Svetislav Zaric, Clinical Lecturer in Periodontology from King's College London. Dr. Zaric explains the implications of their research: "Stroke remains the second leading cause of death globally. Strikingly, the incidence and prevalence of ischemic stroke have been increasing in the younger population during past decades," she said. "Periodontitis, which involves deep inflammation of the gums due to bacteria under the gumline, can lead to systemic effects as bacteria enter the bloodstream and affect other parts of the body," she added.

Burnout is a state of physical, emotional, and mental exhaustion caused by prolonged stress. It can affect anyone, regardless of their profession or personal situation. Recognizing the warning signs of burnout is crucial for taking proactive steps to address it before it leads to more severe health issues. This article will explore the key indicators of burnout and provide practical strategies for managing and preventing it. Physical Symptoms of Burnout Physical symptoms are often the first signs of burnout. These symptoms can manifest in various ways, including chronic fatigue, insomnia, headaches, and muscle tension. Persistent fatigue, even after a full night's sleep, is a significant red flag. This type of exhaustion can make daily tasks feel overwhelming and unmanageable. Insomnia, or difficulty sleeping, is another common physical symptom. Individuals experiencing burnout may find it hard to fall asleep or stay asleep, leading to a vicious cycle of fatigue and sleeplessness. Headaches and muscle tension, particularly in the neck and shoulders, are also prevalent. These symptoms are often caused by the body's prolonged stress response, which keeps muscles in a constant state of tension.

Walgreens Boots Alliance (WBA) has officially announced that Sebastian James, the Managing Director of Boots, will be stepping down from his role to pursue a new opportunity in the healthcare sector. James has given notice to leave the company and will remain with Boots until November. The UK pharmacy giant has already begun the search for a new Managing Director. James is set to take on the role of CEO at Veonet, a leading European chain of ophthalmology clinics. During his tenure as Managing Director since 2018, James played a pivotal role in transforming Boots into the UK's leading health and beauty retailer. He oversaw significant growth and innovation, achieving thirteen consecutive quarters of retail market share growth. Most recently, the company announced strong Q3 results in June with growth across all categories.

"The UK remains genuinely world-leading for life sciences in numerous areas - yet we continue to underperform on our potential," said Richard Torbett, Chief Executive of the Association of the British Pharmaceutical Industry (ABPI). His statement is based on recent government data indicating that the UK is not fully capitalizing on its strong historical and institutional advantages in life sciences across a range of economic, health, and research indicators. The latest 'Life sciences competitiveness indicators 2024' report from the government's Office for Life Sciences revealed that while the pharmaceutical industry leads in R&D spending with £9 billion in 2022, representing a fifth of total business investment, the country saw a notable decline in foreign direct investment (FDI), industry clinical trials, and exports. In 2023, FDI dropped by 21 per cent to £0.8 billion, following a trend that saw a 52 per cent decrease over the previous two years, including a £0.9 billion fall in FDI the year prior.

Leading pharmaceutical wholesaler Lexon UK has completed a £60 million refinancing deal with HSBC UK to help meet its growth targets in 2022 and beyond. The asset based lending facility will support Lexon's business strategy, including capital expenditure in areas such as new technology and business development. Founded in 1995, the Redditch-based supplier has distribution centres in Leeds, Durham and Dublin, supporting thousands of independent pharmacies. Nimesh Sodha, director at Lexon, said: "We are delighted to have completed this deal - it will help Lexon grow and continue to support independent pharmacies across the UK, as we have done for many years, in fresh and exciting ways.

Kailash Deepak Hospital, the leading orthopedic hospital in Delhi, provides exceptional orthopedic care. With a team of highly skilled orthopedic specialists, state-of-the-art facilities, and a patient-centric approach, we are the best hospital in Delhi.

Jackie Giltrow and Jose Moss have been appointed as Chair and Vice-Chair of the Community Pharmacy Patient Safety group, respectively, bringing with them a wealth of experience and expertise in pharmacy practice. Supported by the National Pharmacy Association (NPA) and hosted by the Company Chemists' Association (CCA), the CPPSG serves as a collaborative platform for large community pharmacy organisations to openly share and learn from each other's experiences. A CPPSG Chair now, Jackie Giltrow, Clinical Governance Lead at Paydens Limited is a seasoned pharmacist and expert in risk management and patient safety. With nine years of experience as a member of the CPPSG, Giltrow's appointment represents a continuation of her longstanding dedication to advancing patient safety initiatives within community pharmacy settings.

protein helps your hair grow and lose weight -Researchers have showed how hair growth activated fat tissue growth within the skin below the follicle may lead to the development of a cream to dissolve fat. particularly, the protein that activated follicle growth was shown to conjointly inhibit fat production

People consume alcohol for some temporary enjoyment to feel the high. But gradually with continuous consumption this temporary enjoyment turns into addiction, which is not only injurious to health but also negatively affects the mind. Addiction becomes a curse when it goes out of hand and engulfs a person completely barring him from leading a normal life.